Cecelia Health Completes $13 Million Series B Financing to Transform Lives of People Living with Diabetes and Other Chronic Conditions Rittenhouse Ventures and Endo Investors lead oversubscribed round, joined by Boston Millennia Partners, SustainVC and G100 Capital NEW YORK, August 13, 2020-- Cecelia Health, a leading technology-enabled diabetes and other chronic disease management company, announced today it has completed a $13 million Series B funding round. The investment was co-led by Rittenhouse Ventures and Endo Investors, and includes investments from Boston Millennia Partners, SustainVC, G100 Capital, and others.